The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $18.75 for the day, down -3.55% from the previous closing price of $19.44. In other words, the price has decreased by -$3.55 from its previous closing price. On the day, 48.61 million shares were traded. HIMS stock price reached its highest trading level at $19.1699 during the session, while it also had its lowest trading level at $18.29.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.35. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
Citigroup Downgraded its Buy to Neutral on May 22, 2024, whereas the target price for the stock was revised from $16 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 07 ’24 when Baird Melissa sold 58,750 shares for $19.57 per share. The transaction valued at 1,149,625 led to the insider holds 630,166 shares of the business.
Okupe Oluyemi sold 9,868 shares of HIMS for $196,992 on Oct 07 ’24. The Chief Financial Officer now owns 195,988 shares after completing the transaction at $19.96 per share. On Oct 07 ’24, another insider, Melissa Baird, who serves as the Officer of the company, bought 58,750 shares for $19.44 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 4058362624 and an Enterprise Value of 4004215808. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 250.67, and their Forward P/E ratio for the next fiscal year is 25.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.80 while its Price-to-Book (P/B) ratio in mrq is 11.23. Its current Enterprise Value per Revenue stands at 3.752 whereas that against EBITDA is 149.472.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $25.74, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is 13.09%, while the 200-Day Moving Average is calculated to be 23.12%.
Shares Statistics:
HIMS traded an average of 8.75M shares per day over the past three months and 14641130 shares per day over the past ten days. A total of 205.10M shares are outstanding, with a floating share count of 173.97M. Insiders hold about 19.63% of the company’s shares, while institutions hold 56.84% stake in the company. Shares short for HIMS as of 1726185600 were 26537491 with a Short Ratio of 3.03, compared to 1723680000 on 23042592. Therefore, it implies a Short% of Shares Outstanding of 26537491 and a Short% of Float of 13.99.
